• February 14, 2017 at 3:39 pm #1219
    Profile photo of adminadmin
    Keymaster

    Regen BioPharma, Inc. (RGBP) focuses on the development of regenerative medical applications in the United States. It intends to provide various products, including HemaXellerate I, a cellular therapy designed to heal damaged bone marrows; HemaXellerate II, a donor endothelial cell based therapeutic product; dCellVax, a gene silenced dendritic cell immunotherapy for the treatment of breast cancer; and NR2F6, a nuclear receptor cell line. The company was founded in 2012 and is based in La Mesa, California. Regen BioPharma, Inc. is a subsidiary of Bio-Matrix Scientific Group, Inc.

    • This topic was modified 5 months, 3 weeks ago by admin.
    • This topic was modified 4 months, 2 weeks ago by admin.
    • This topic was modified 4 months, 2 weeks ago by admin.
    • This topic was modified 4 months, 2 weeks ago by tomasp.
    • This topic was modified 4 months, 2 weeks ago by tomasp.
    • This topic was modified 4 months, 2 weeks ago by tomasp.
    • This topic was modified 4 months, 2 weeks ago by tomasp.
    • This topic was modified 4 months, 2 weeks ago by tomasp.
    • This topic was modified 4 months, 2 weeks ago by tomasp.

You must be logged in to reply to this topic.